[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"important-message":3,"cookie-copy":16,"mainMenu":23,"onboarding":24,"contribution-page-SE-0-SE-6-17106":199,"footer":775},{"data":4,"show":5},{"active":5,"title":6,"message":9,"link":12,"link_text":14,"starttime":15,"endtime":13},false,{"en":7,"sv":8},"The website is currently experiencing technical issues ","Tekniska problem",{"en":10,"sv":11},"We are currently experiencing technical issues and are working to restore the website as soon as possible. Please try again later.\r\n\r\nContact openaid@sida.se for more information.","Vi har just nu tekniska problem och arbetar med att återställa webbplatsen. Försök gärna igen senare.\r\n\r\nKontakta openaid@sida.se vid frågor.\r\n",{"en":13,"sv":13},"",{"en":13,"sv":13},"2026-08-18T10:41:32",{"content":17,"modalContent":20},{"en":18,"sv":19},"\u003Cp>Openaid.se uses cookies to improve your experience as a user, including cookies for web analytics and cookies that help the website function properly. Cookies that handle your selection in this box cannot be opted out. \u003Ca href=\"https:\u002F\u002Fopenaid.se\u002Fen\u002Fabout-openaid\u002Fabout-the-website\">Read more about cookies at Openaid.se\u003C\u002Fa>\u003C\u002Fp>\n","\u003Cp>Openaid.se använder kakor för att förbättra upplevelsen för dig som användare, bland annat kakor för webbanalys och kakor som bidrar till att webbplatsen fungerar korrekt. Kakor som hanterar ditt val i denna ruta går inte att välja bort. \u003Ca href=\"https:\u002F\u002Fopenaid.se\u002Fabout-openaid\u002Fabout-the-website\">Läs mer om kakor på Openaid.se\u003C\u002Fa>\u003C\u002Fp>\n",{"en":21,"sv":22},"\u003Cp>Openaid.se use necessary and functional cookies to make our website work. We also use cookies to improve website functionality by obtaining statistics on how the site is used. You can change your settings here at any time. \u003Ca href=\"https:\u002F\u002Fopenaid.se\u002Fen\u002Fabout-openaid\u002Fabout-the-website\">Read more\u003C\u002Fa>\u003C\u002Fp>\n","\u003Cp>Här godkänner du vilka kakor webbplatsen får spara i din dator. Du kan när som helst ändra dina inställningar. \u003Ca href=\"https:\u002F\u002Fopenaid.se\u002Fabout-openaid\u002Fabout-the-website\">Läs mer om kakor på Openaid.se\u003C\u002Fa>\u003C\u002Fp>\n",{},{"help":25,"intro":73,"tour":128},{"data":26,"enabled":72},{"page_description":27,"tour_description":52,"intro_description":62},[28,34,40,46],{"page":29,"description":31},{"en":30,"sv":30},"%2Ffind-aid%2Fsector-category",{"en":32,"sv":33},"On this page sector categories are listed and can be filtered by year or search keyword.","På den här sidan listas sektorkategorier, som beskriver vilket specifikt område hos en mottagare som en aktivitet ska gynna och utveckla. Dessa kan filtreras på år och sökord.",{"page":35,"description":37},{"en":36,"sv":36},"%2Ffind-aid%2Fdonors",{"en":38,"sv":39},"On this page responsible government agencies are listed and can be filtered by year or search keyword.","På den här sidan listas ansvariga myndigheter. Dessa kan filtreras på år och sökord.",{"page":41,"description":43},{"en":42,"sv":42},"%2Ffind-aid%2Fcountries-and-regions",{"en":44,"sv":45},"On this page countries and regions are listed.","På den här sidan listas länder och regioner där Sverige bedriver utvecklingssamarbete och där stöd ska bidra till utvecklingsresultat.",{"page":47,"description":49},{"en":48,"sv":48},"%2Ffind-aid%2Fpartners",{"en":50,"sv":51},"Choose a partner that Swedish government agencies cooperate with to implement Swedish aid.","På den här sidan listas samarbetspartner som ansvariga myndigheter samarbetar med för att genomföra biståndet.",{"title":53,"description":56,"button_text":59},{"en":54,"sv":55},"Do you need help?","Vill du ha hjälp att utforska biståndet?",{"en":57,"sv":58},"Join a tour and get tips on what to do on this page.","Följ med på en rundtur med tips på vad du kan göra på denna sida.",{"en":60,"sv":61},"Start the tour","Visa mig runt på sidan",{"title":63,"description":66,"button_text":69},{"en":64,"sv":65},"Do you want to know more about Openaid?","Vill du veta mer om Openaid?",{"en":67,"sv":68},"Here you will get a quick introduction to Openaid and what you can do on this website.","Här får du en snabb introduktion till vad Openaid är och vad du kan göra på webbplatsen.",{"en":70,"sv":71},"Start introduction","Starta introduktionen",true,{"data":74,"enabled":72},[75,83,91,101,111,120],{"title":76,"description":79,"other_info":82},{"en":77,"sv":78},"Welcome to Openaid","Välkommen till Openaid",{"en":80,"sv":81},"Here you will find information about when, to whom and for what purpose Swedish aid funds have been disbursed since 1998. You can also see the results that have been achieved. ","Här kan du se när, till vem och för vilket ändamål svenskt statligt bistånd har betalats ut sedan 1998. Du kan också se biståndets resultat. ",{"en":13,"sv":13},{"title":84,"description":87,"other_info":90},{"en":85,"sv":86},"Openaid shows data from different agencies","Openaid visar data från olika myndigheter",{"en":88,"sv":89},"Statistics and payments from all Swedish government agencies handling funds in the Expenditure area 7: International aid form the basis for the data presented on Openaid.","På Openaid kan du hitta statistik och utbetalningar från alla myndigheter och departement som hanterar statliga biståndsmedel.",{"en":13,"sv":13},{"title":92,"description":95,"other_info":98},{"en":93,"sv":94},"Choose what data you want to see","Välj vilken data du vill se",{"en":96,"sv":97},"You can choose to see data from specific agencies, to specific countries or regions or within specific sectors. You can also see contributions performed by a specific partner.","Du kan välja att se data från vissa myndigheter, till vissa geografiska områden eller inom vissa sektorkategorier, som beskriver vilket temaområde en insats genomförs i. Du kan också se insatser som utförts av en viss samarbetspartner.",{"en":99,"sv":100},"Openaid is continuously updated. This means that for the current and previous year, sums are updated as data is reported and published. ","Openaid uppdateras löpande. Det innebär att för nuvarande år och föregående år uppdateras summor i takt med att data rapporteras in och publiceras. ",{"title":102,"description":105,"other_info":108},{"en":103,"sv":104},"See contributions","Se enskilda biståndsinsatser",{"en":106,"sv":107},"You can get in-depth information about a contribution. Here you can see results, transactions and documents. ","Du kan få fördjupad information om en enskild insats som gjorts inom biståndet. Här kan du se resultat, transaktioner och dokument. ",{"en":109,"sv":110},"The website’s data can be exported. ","All data på Openaid går att exportera. ",{"title":112,"description":114,"other_info":117},{"en":54,"sv":113},"Hjälpen är alltid nära",{"en":115,"sv":116},"Locate the button with a question mark in the lower right corner!","På Openaid finns fler tips på vad du kan göra. Leta upp knappen med frågetecknet i högra hörnet!",{"en":118,"sv":119},"For questions, please contact openaid@sida.se.","Vid frågor, kontakta openaid@sida.se.",{"title":121,"description":124,"other_info":127},{"en":122,"sv":123},"Explore aid","Är du redo att utforska biståndet?",{"en":125,"sv":126},"Start exploring the Swedish development cooperation on Openaid. Either on your own or by joining the tour.","Nu kan du börja utforska biståndet på Openaid – antingen på egen hand eller genom att följa med på en rundtur.",{"en":13,"sv":13},{"data":129,"enabled":72},{"general":130,"startpage":150,"explore_aid":165},[131,141],{"id":132,"title":133,"description":136,"other_info":139},"explore-aid-menu-button",{"en":134,"sv":135},"Find all Swedish aid","Hitta till allt bistånd",{"en":137,"sv":138},"Here you can find data based on responsible agencies, countries and regions, partners, sector categories, strategies and The Sustainable Development Goals. ","Här kan du hitta bistånd utifrån ansvarig myndighet, länder och regioner, samarbetspartner, sektorkategorier, strategier och Globala målen. ",{"en":140,"sv":140},null,{"id":142,"title":143,"description":146,"other_info":149},"main-search",{"en":144,"sv":145},"Search the site","Sök på webbplatsen",{"en":147,"sv":148},"Here you can search for any content on the site, for example a country, a contribution or a document.","Här kan du söka på allt innehåll efter till exempel ett land, en insats eller ett dokument.",{"en":140,"sv":140},[151,160],{"id":152,"title":153,"description":156,"other_info":159},"show-aid-button",{"en":154,"sv":155},"Explore aid on your own","Utforska biståndet på egen hand",{"en":157,"sv":158},"You can choose which responsible agencies you want to see Swedish aid from, to which geographical areas and within which sector categories.","Du kan välja vilka ansvariga myndigheter du vill se bistånd från, till vilka geografiska områden samt inom vilka sektorkategorier. ",{"en":140,"sv":140},{"id":161,"title":162,"description":163,"other_info":164},"more-choices-filter-button",{"en":13,"sv":13},{"en":13,"sv":13},{"en":140,"sv":140},[166,171,176,181,190],{"id":167,"title":168,"description":169,"other_info":170},"comparison-filter-card",{"en":13,"sv":13},{"en":13,"sv":13},{"en":140,"sv":140},{"id":172,"title":173,"description":174,"other_info":175},"comparison-filter-modal-trigger",{"en":13,"sv":13},{"en":13,"sv":13},{"en":140,"sv":140},{"id":177,"title":178,"description":179,"other_info":180},"add-comparison-button",{"en":13,"sv":13},{"en":13,"sv":13},{"en":140,"sv":140},{"id":182,"title":183,"description":186,"other_info":189},"compare-explore-aid-navigation",{"en":184,"sv":185},"See how the aid is distributed","Se hur biståndet är fördelat",{"en":187,"sv":188},"Here you can see how the Swedish aid has been distributed based on your filter options.","Här kan du snabbt navigera och se hur biståndet har fördelats utifrån de val du har gjort.",{"en":140,"sv":140},{"id":191,"title":192,"description":195,"other_info":198},"export-button",{"en":193,"sv":194},"Export data","Exportera data",{"en":196,"sv":197},"You can export the data in xls-format.","Här kan kan du exportera data i xls-format.",{"en":140,"sv":140},{"contribution":200,"activities":410,"paidTransactions":740,"transactions":765,"strategies":774},{"iatiidentifier":201,"reportingorg":202,"title":207,"descriptions":212,"participatingorgs":225,"activitystatus":232,"activitydates":233,"defaultflowtype":239,"contactinfo":240,"recipientCountries":247,"recipientregions":252,"sectors":257,"documentlinks":270,"result":311,"relatedactivities":326,"lastupdateddatetime":329,"lang":274,"defaultcurrency":330,"hierarchy":219,"humanitarianSpecified":5,"hasHumanitarianActivity":5,"hasLongtermActivity":72,"transactionsMetadata":331,"activitiesMetadata":405},"SE-0-SE-6-17106",{"narrative":203,"ref":204,"type":205,"secondaryreporter":206},"Sweden","SE-0",10,0,[208,211],{"lang":209,"value":210},"sv","International Vaccine Institute IVI 2025-2028",{"value":210},[213,220],{"narrative":214,"type":219},[215,217],{"value":216},"International Vaccine Institute, IVI, was established in 1997 as a multilateral research institute which develops vaccines in order to reduce the burden of poverty-related disease. IVI offers technical assistance to vaccine producers and regulators in low- and lower-middle-income countries, and maintains an international network of collaborating research institutions.\n\nSida has supported IVI since 2002, and provides non-earmarked program support to IVI's strategy implementation.",{"lang":209,"value":218},"International Vaccine Institute, IVI, är en multilateral forskningsorganisation som grundades 1997. Verksamheten inriktas på att producera och sprida vaccin mot infektioner som främst drabbar de som lever i fattigdom, i synnerhet diarré- och luftvägssjukdomar. Sverige är signatärstat och medlem i IVI sedan 1997 (Regeringsbeslut 1996-12-19, UD96\u002F1555\u002FGC). \n\nInstitutet har samarbete med cirka 50 partners runtom i världen, vilka inkluderar forskningsinstitutioner och universitet, regeringar, läkemedelsföretag och vaccintillverkare. Dessa globala samarbeten och partnerskap bidrar till att säkerställa hållbar tillgång av effektiva och prisvärda vacciner för människor som lever i fattigdom. \n\nSida har stött IVI sedan 2002 med ett brett programstöd till institutets verksamhetsplan.",1,{"narrative":221,"type":224},[222],{"lang":209,"value":223},"IVI:s främsta syfte är att utveckla vaccin mot sjukdomar som främst drabbar människor som lever i fattigdom, för att därigenom främja en förbättrad global folkhälsa. De arbetar också med att möjliggöra vaccination, bland annat genom att ta fram data över effektivitet, sjukdomsspridning och antimikrobiell resistens och genom att stötta länders regulatoriska system i låg- och medelinkomstländer (LMIC). Genom vaccination och efterföljande minskning av sjukdomsbördan finns en rad positiva effekter för samhället i stort.\n\nIVIs vision är utvecklingsländer fria från infektionssjukdomar. För att åstadkomma detta, utvecklar IVI vaccin mot just  infektionssjukdomar med stor vikt för global folkhälsa och vars bot har begränsad kommersiell potential.\n\nDeras nuvarande strategi, 2022-2026, har tre huvudsakliga mål:\n\n- Förstärka IVIs kärnverksamhet: forskning och utveckling, inklusive laboratorieforskning, tekniköverföring, klinisk vaccinutveckling, epidemiologi och övervakning, vaccineffektivitet. Detta ihop med kapacitetsstärkande program och AMR-projekt.\n\n- Skala upp det globala avtrycket: utöka internationell närvaro och öka antalet medlemsländer i IVI.\n\n- Framtidssyftande styrning: Skapa en mer inkluderande och lyhörd styrningsstruktur genom att integrera fler IVI-medlemsstater i institutionell styrning.\n\nUnder kommande år, kommer flera nya kontor att etableras och driva sin egen lokalt anpassade verksamhet. IVI förväntas delta i allt fler globala sammanhang (ex WHO, Gavi, afrikanska vaccinsatsningar), de har flera vaccin i pipeline och genomför förändringen i styrning av institutet. Om fyra år kan vi räkna med två afrikanska kontor med etablerad närvaro i fler länder på kontinenten, en mera inkluderande styrningsstruktur och större ägarskap och ledarskap i länderna där arbetet genomförs. Utöver detta, en rad viktiga resultat inom vaccinutveckling, stöd till vaccinationsprogram på lokal nivå, och deltagande i en rad kliniska studier.\n\nFör 2025 bidrar Sida med extra medel för att stärka IVI:s etablering på den afrikanska kontinenten.",2,[226,228],{"narrative":203,"ref":204,"crsChannelCode":227,"type":205,"typeSpecified":72,"role":219},"11001",{"narrative":229,"ref":230,"crsChannelCode":227,"type":205,"typeSpecified":72,"role":231},"Swedish International Development Cooperation Agency","SE-6",3,{"code":224},[234,236,238],{"type":224,"isodate":235},"2024-07-30T00:00:00",{"type":231,"isodate":237},"2029-09-30T00:00:00",{"type":219,"isodate":235},{"code":205},{"organisation":241,"telephone":242,"email":243,"website":244,"mailingaddress":245},{"narrative":229},"+46 8 698 50 00","sida@sida.se","www.sida.se",{"narrative":246},"Box 2025, 174 02 Sundbyberg, Sweden",[248],{"narrative":249,"code":250,"percentage":251},"Rwanda","RW",30,[253],{"narrative":254,"code":255,"percentage":256},"Developing countries, unspecified","998",70,[258,261,264,267],{"narrative":259,"code":260,"vocabulary":219,"percentage":256},"Medical research",12182,{"narrative":262,"code":263,"vocabulary":219,"percentage":251},"Infectious disease control",12250,{"narrative":265,"code":266,"vocabulary":224,"percentage":256},"Health, General",121,{"narrative":268,"code":269,"vocabulary":224,"percentage":251},"Basic Health",122,[271,280,286,293,299,305],{"title":272,"category":276,"url":278,"format":279},{"narrative":273},{"lang":274,"value":275},"en","International Vaccine Institute (IVI) 2025-2028 Agreement",{"code":277},"A04","https:\u002F\u002Fdocuments.iati.openaid.se\u002Fdocument\u002Frwanda-and-burundi\u002F17106_17106IVIAgreement2025-2028.pdf","application\u002Fpdf",{"title":281,"category":284,"url":285,"format":279},{"narrative":282},{"lang":274,"value":283},"International Vaccine Institute (IVI) Agreement Amendment 2025-2028",{"code":277},"https:\u002F\u002Fdocuments.iati.openaid.se\u002Fdocument\u002Frwanda-and-burundi\u002F17106_17106IVIAgreementAmendment12025-2028.pdf",{"title":287,"category":290,"url":292,"format":279},{"narrative":288},{"lang":274,"value":289},"International Vaccine Institute (IVI) Decion on Amendment of Contribution",{"code":291},"A05","https:\u002F\u002Fdocuments.iati.openaid.se\u002Fdocument\u002Frwanda-and-burundi\u002F17106_17106IVIDecisiononAmendmentofContribution2025-2028.pdf",{"title":294,"category":297,"url":298,"format":279},{"narrative":295},{"lang":274,"value":296},"IVI Decision on Contribution ",{"code":291},"https:\u002F\u002Fdocuments.iati.openaid.se\u002Fdocument\u002Frwanda-and-burundi\u002F17106_17106IVIDecisiononContribution2025-2028.pdf",{"title":300,"category":303,"url":304,"format":279},{"narrative":301},{"lang":209,"value":302},"17106_Beslutominsats(17106).pdf",{"code":291},"https:\u002F\u002Fdocuments.iati.openaid.se\u002Fdocument\u002Fforsk\u002F17106_Beslutominsats(17106).pdf",{"title":306,"category":309,"url":310,"format":279},{"narrative":307},{"lang":274,"value":308},"17106_AgreementSida-IVI2025-2028_Finalsigned.pdf",{"code":277},"https:\u002F\u002Fdocuments.iati.openaid.se\u002Fdocument\u002Fforsk\u002F17106_AgreementSida-IVI2025-2028_Finalsigned.pdf",{"title":312,"description":317,"indicator":320,"type":224,"aggregationstatus":206},[313,315],{"value":314},"Results achieved",{"lang":209,"value":316},"Uppnådda resultat",[318],{"lang":209,"value":319},"(text in English as the contribution is handled by the Embassy of Sweden in Rwanda)\n\nResults show that the International Vaccine Institute (IVI) is not only advancing science but also making sure vaccines are more affordable, accessible, and locally produced. By opening offices in Africa and Asia, IVI is bringing research closer to where its most needed. And by training hundreds of professionals, they are building the skills and systems that ensure vaccines reach people everywhere.\n\nSince the start of Sida's support in January 2025 the following results, aligned with the IVI strategy, have been achieved:\n\nStrengthen IVIs Core Activities\n\n(Discovery, development, delivery, capacity building)\n\n- The microneedle array patch with HepB vaccine phase 1 trial (first in human) was fully enrolled with 40 healthy individuals. \n\n- Malaria vaccine registration in DRC was supported and almost 3 500 participants are enrolled.\n\n- IVI's \"Vaccine number 4\" program was initiated, aiming for a vaccine against Klebsiella pneumoniae. \n\n- Clinical trial initiating for the tech-transferred cholera vaccine to South-African company Biovac (OCV-S, first ever manufacturing of full vaccine in Africa) in South Africa (see more https:\u002F\u002Fhealthpolicy-watch.news\u002Fsouth-africa-launches-trial-of-first-african-made-cholera-vaccine\u002F). The OCV-S is an improved and simplified version of the cholera vaccine, and with the same investment 30% more vaccine can be manufactured to a 20% lower price. \n\n- In addition, IVI is progressing towards an entercoated capsule of the cholera vaccine, which will be heat stable, have lower delivery costs, and lead to less waste. \n\nCapacity strengthening\n\n- IVI vaccinology course: the one-week training in vaccinology took place in three locations simultaneously in both 2024 and 2025 (Seoul, Stockholm and Kigali). Trainers are present in all three locations, and recordings were shared online to accommodate for time differences. In Kigali 2025 there were around 85 participants from 15 countries (Nigeria, Somalia, DR Congo, Uganda, Tanzania, Kenya, Rwanda, Zambia, India, Germany, UK, Ethiopia...). Presenters were from public and private sectors, donors and multilaterals (WHO, Unicef). Sida did one of the welcome remarks at the Kigali site. \n\nImportant discussions were held around the outbreak of Marburg in Rwanda 2024: how this was handled and lessons learned. Rwandan authorities as well as WHO and CEPI were present. Although the outbreak was exceptionally handled, there was an interesting discussion on even faster protocols for clinical trials on vaccines. \n\n- Global Training Hub for Biomanufacturing took place, providing workforce training in vaccine and biologics R&D and manufacturing for students and professionals from low- and middle-income countries.\n\n- IVI hosted 2025 Introductory Course for Standard Practice (GxP) as part of WHO biomanufacturing training initiative, a three-week in-person program. It trained 192 international participants from 39 countries, along with 21 Korean participants from domestic biopharmaceutical companies and graduate programs. The trainees include professionals from organizations involved in the development and manufacturing of biopharmaceuticals such as vaccines, therapeutics, and monoclonal antibodies in LMICs.\n\n- In connection to the IVI Board of Trustees meeting in Kigali November 2025, a symposium was organized by IVI and the University of Rwanda with world-leading global health experts. This opportunity was important in particular for MAV participants and others involved in vaccines R&D. \n\nScale Up the Global Footprint\n\n- Establishment of the IVI African Regional Office in Kigali (IARO) with a Director and two team members (admin assistant and operations specialist).\n\n- Recent establishment of the IVI Project Office in Nairobi with a Director (November).\n\n- Hong Kong Jockey Club Global Health Institute (a joint initiative between IVI, Cambridge and Hong Kong University) was inaugurated in October\n\n- New grants in 2025 (as of October) are almost 78 million USD.  \n\n- 60 countries and WHO have now joined as IVI members or are in process of joining.\n\nFuture-Oriented Governance\n\n- As a result of the new offices, resulting in a new IVI structure, a new governance structure is being put in place. The IERO (European Regional Office) and IARO Directors are members of the IVI leadership team and report directly to the DG. The process is still ongoing.\n\n- A risk management unit was established at HQ, and a number of activities were implemented such as a cybersecurity audit by KPMG. \n\n- A risk coordination network shall be fully functional as of December 2025.\n\n - IVI is ranked as a \"high performer\" in the Global 50\u002F50 gender and health index.",{"title":321,"description":323,"measure":325,"ascending":206},{"narrative":322},"Not applicable",{"narrative":324},"No indicator available - only a description of the activity results is published",5,[327],{"ref":328,"type":224},"SE-0-SE-6-17106-17106A0101","2026-11-11T04:29:29+00:00","SEK",[332,352,357,362,366,371,376,381,385,391,396,401],{"accountableOrganisation":333,"thematicAreas":334,"code":231,"agency":230,"aidType":336,"collaborationType":224,"sector":260,"sectorCategory":337,"humanitarian":5,"sdgs":338,"sdgCategories":344,"activity":328,"year":348,"value":349,"recipient":250,"strategy":350,"strategyEndDate":351,"organisation":333},"47074:ivi\u002Finternational_vaccine_institute",[335],"poverty-reduction-through-job-creation,-trade-and-education","B021",120,[339,340,341,342,343],"17.6","3.3","3.b","3.d","9.5",[345,346,347],"17.0","3.0","9.0",2024,1260000,1140103,"2028-12-31T00:00:00",{"accountableOrganisation":333,"thematicAreas":353,"code":231,"agency":230,"aidType":336,"collaborationType":224,"sector":263,"sectorCategory":337,"humanitarian":5,"sdgs":354,"sdgCategories":355,"activity":328,"year":348,"value":356,"recipient":250,"strategy":350,"strategyEndDate":351,"organisation":333},[335],[339,340,341,342,343],[345,346,347],540000,{"accountableOrganisation":333,"thematicAreas":358,"code":231,"agency":230,"aidType":336,"collaborationType":224,"sector":260,"sectorCategory":337,"humanitarian":5,"sdgs":359,"sdgCategories":360,"activity":328,"year":348,"value":361,"recipient":255,"strategy":350,"strategyEndDate":351,"organisation":333},[335],[339,340,341,342,343],[345,346,347],2940000,{"accountableOrganisation":333,"thematicAreas":363,"code":231,"agency":230,"aidType":336,"collaborationType":224,"sector":263,"sectorCategory":337,"humanitarian":5,"sdgs":364,"sdgCategories":365,"activity":328,"year":348,"value":349,"recipient":255,"strategy":350,"strategyEndDate":351,"organisation":333},[335],[339,340,341,342,343],[345,346,347],{"accountableOrganisation":333,"thematicAreas":367,"code":231,"agency":230,"aidType":336,"collaborationType":224,"sector":260,"sectorCategory":337,"humanitarian":5,"sdgs":368,"sdgCategories":369,"activity":328,"year":348,"value":370,"recipient":255,"strategy":350,"strategyEndDate":351,"organisation":333},[335],[339,340,341,342,343],[345,346,347],4900000,{"accountableOrganisation":333,"thematicAreas":372,"code":231,"agency":230,"aidType":336,"collaborationType":224,"sector":260,"sectorCategory":337,"humanitarian":5,"sdgs":373,"sdgCategories":374,"activity":328,"year":348,"value":375,"recipient":250,"strategy":350,"strategyEndDate":351,"organisation":333},[335],[339,340,341,342,343],[345,346,347],2100000,{"accountableOrganisation":333,"thematicAreas":377,"code":231,"agency":230,"aidType":336,"collaborationType":224,"sector":263,"sectorCategory":337,"humanitarian":5,"sdgs":378,"sdgCategories":379,"activity":328,"year":348,"value":380,"recipient":250,"strategy":350,"strategyEndDate":351,"organisation":333},[335],[339,340,341,342,343],[345,346,347],900000,{"accountableOrganisation":333,"thematicAreas":382,"code":231,"agency":230,"aidType":336,"collaborationType":224,"sector":263,"sectorCategory":337,"humanitarian":5,"sdgs":383,"sdgCategories":384,"activity":328,"year":348,"value":375,"recipient":255,"strategy":350,"strategyEndDate":351,"organisation":333},[335],[339,340,341,342,343],[345,346,347],{"accountableOrganisation":333,"thematicAreas":386,"code":231,"agency":230,"aidType":336,"collaborationType":224,"sector":263,"sectorCategory":337,"humanitarian":5,"sdgs":387,"sdgCategories":388,"activity":328,"year":389,"value":390,"recipient":250,"strategy":350,"strategyEndDate":351,"organisation":333},[335],[339,340,341,342,343],[345,346,347],2026,270000,{"accountableOrganisation":333,"thematicAreas":392,"code":231,"agency":230,"aidType":336,"collaborationType":224,"sector":260,"sectorCategory":337,"humanitarian":5,"sdgs":393,"sdgCategories":394,"activity":328,"year":389,"value":395,"recipient":255,"strategy":350,"strategyEndDate":351,"organisation":333},[335],[339,340,341,342,343],[345,346,347],1470000,{"accountableOrganisation":333,"thematicAreas":397,"code":231,"agency":230,"aidType":336,"collaborationType":224,"sector":263,"sectorCategory":337,"humanitarian":5,"sdgs":398,"sdgCategories":399,"activity":328,"year":389,"value":400,"recipient":255,"strategy":350,"strategyEndDate":351,"organisation":333},[335],[339,340,341,342,343],[345,346,347],630000,{"accountableOrganisation":333,"thematicAreas":402,"code":231,"agency":230,"aidType":336,"collaborationType":224,"sector":260,"sectorCategory":337,"humanitarian":5,"sdgs":403,"sdgCategories":404,"activity":328,"year":389,"value":400,"recipient":250,"strategy":350,"strategyEndDate":351,"organisation":333},[335],[339,340,341,342,343],[345,346,347],{"organisations":406},[407],{"role":408,"id":333,"name":409},4,"IVI\u002FInternational Vaccine Institute",[411],{"iatiidentifier":328,"reportingorg":412,"title":413,"descriptions":416,"participatingorgs":424,"activitystatus":432,"activitydates":433,"tags":437,"policymarkers":468,"collaborationtype":489,"defaultfinancetype":490,"defaultaidtype":492,"defaulttiedstatus":493,"budgets":494,"planneddisbursements":527,"transactions":558,"relatedActivities":693,"strategies":695,"lastupdateddatetime":329,"lang":274,"defaultcurrency":330,"hierarchy":224,"humanitarian":206,"humanitarianSpecified":72},{"narrative":203,"ref":204,"type":205,"secondaryreporter":206},[414,415],{"value":210},{"lang":209,"value":210},[417,421],{"narrative":418,"type":219},[419,420],{"value":216},{"lang":209,"value":218},{"narrative":422,"type":224},[423],{"lang":209,"value":223},[425,426,430,431],{"narrative":203,"ref":204,"crsChannelCode":227,"type":205,"typeSpecified":72,"role":219},{"narrative":409,"ref":427,"crsChannelCode":428,"type":429,"typeSpecified":72,"role":224},"US-EIN-13-3870223","47074",40,{"narrative":229,"ref":230,"crsChannelCode":227,"type":205,"typeSpecified":72,"role":231},{"narrative":409,"ref":427,"crsChannelCode":428,"type":429,"typeSpecified":72,"role":408},{"code":224},[434,435,436],{"type":224,"isodate":235},{"type":231,"isodate":237},{"type":219,"isodate":235},[438,444,450,456,462],{"narrative":439,"code":339,"vocabulary":231},[440,442],{"lang":209,"value":441},"17.6 - Stärka nord–syd-samarbetet, syd–syd-samarbetet och det regionala och internationella trepartssamarbetet kring och tillgången till vetenskap, teknik och innovation samt öka kunskapsutbytet på gemensamt överenskomna villkor, inklusive genom förbättrad samordning mellan befintliga mekanismer, i synnerhet på FN-nivå, och genom en global mekanism för teknikfrämjande.",{"value":443},"17.6 - Enhance North-South, South-South and triangular regional and international cooperation on and access to science, technology and innovation and enhance knowledge-sharing on mutually agreed terms, including through improved coordination among existing mechanisms, in particular at the United Nations level, and through a global technology facilitation mechanism.",{"narrative":445,"code":340,"vocabulary":231},[446,448],{"lang":209,"value":447},"3.3 - Senast 2030 utrota epidemierna av aids, tuberkulos, malaria och försummade tropiska sjukdomar samt bekämpa hepatit, vattenburna sjukdomar och andra smittsamma sjukdomar.",{"value":449},"3.3 - By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases.",{"narrative":451,"code":341,"vocabulary":231},[452,454],{"value":453},"3.b - Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public healt",{"lang":209,"value":455},"3.b - Stödja forskning om och utveckling av vaccin och läkemedel mot de smittsamma och icke-smittsamma sjukdomar som i första hand drabbar utvecklingsländer. Sörja för tillgång till ekonomiskt överkomliga grundläggande läkemedel och vaccin, i enlighet med Doha-deklarationen om TRIPS-avtalet och folkhälsa, i vilken det bekräftas att utvecklingsländerna har rätt att fullt ut utnyttja den flexibilitet som avtalet om handelsrelaterade aspekter av immaterialrätter erbjuder för att skydda folkhälsan och, framför ",{"narrative":457,"code":342,"vocabulary":231},[458,460],{"value":459},"3.d - Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks.",{"lang":209,"value":461},"3.d - Stärka alla länders, i synnerhet utvecklingsländernas, kapacitet när det gäller tidig varning, riskreducering och hantering av nationella och globala hälsorisker.",{"narrative":463,"code":343,"vocabulary":231},[464,466],{"lang":209,"value":465},"9.5 - Förbättra forskningen och industrisektorernas tekniska kapacitet i alla länder, i synnerhet utvecklingsländerna, bland annat genom att till 2030 uppmuntra innovation och väsentligt öka det antal personer som arbetar med forskning och utveckling per 1 miljon människor liksom de offentliga och privata utgifterna för forskning och utveckling.",{"value":467},"9.5 - Enhance scientific research, upgrade the technological capabilities of industrial sectors in all countries, in particular developing countries, including, by 2030, encouraging innovation and substantially increasing the number of research and development workers per 1 million people and public and private research and development spending.",[469,471,473,475,478,481,484,486],{"narrative":470,"code":219,"vocabulary":219,"significance":206},"Gender Equality",{"narrative":472,"code":224,"vocabulary":219,"significance":206},"Aid to Environment",{"narrative":474,"code":325,"vocabulary":219,"significance":206},"Aid Targeting the Objectives of the Convention on Biological Diversity",{"narrative":476,"code":477,"vocabulary":219,"significance":206},"Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation",6,{"narrative":479,"code":480,"vocabulary":219,"significance":206},"Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation",7,{"narrative":482,"code":483,"vocabulary":219,"significance":206},"Aid Targeting the Objectives of the Convention to Combat Desertification",8,{"narrative":485,"code":205,"vocabulary":219,"significance":206},"Disaster Risk Reduction(DRR)",{"narrative":487,"code":488,"vocabulary":219,"significance":206},"Disability",11,{"code":224},{"code":491},110,{"code":336},{"code":325},[495,502,508,515,521],{"periodstart":496,"periodend":498,"value":500},{"isodate":497},"2024-01-01T00:00:00",{"isodate":499},"2024-12-28T00:00:00",{"valuedate":497,"value":501},16000000,{"periodstart":503,"periodend":505,"value":507},{"isodate":504},"2025-01-01T00:00:00",{"isodate":506},"2025-12-28T00:00:00",{"valuedate":504,"value":206},{"periodstart":509,"periodend":511,"value":513},{"isodate":510},"2026-01-01T00:00:00",{"isodate":512},"2026-12-28T00:00:00",{"valuedate":510,"value":514},3000000,{"periodstart":516,"periodend":518,"value":520},{"isodate":517},"2027-01-01T00:00:00",{"isodate":519},"2027-12-28T00:00:00",{"valuedate":517,"value":514},{"periodstart":522,"periodend":524,"value":526},{"isodate":523},"2028-01-01T00:00:00",{"isodate":525},"2028-12-28T00:00:00",{"valuedate":523,"value":514},[528,533,538,543,548,553],{"periodstart":529,"periodend":530,"value":531},{"isodate":504},{"isodate":506},{"valuedate":532,"value":206},"2025-05-01T00:00:00",{"periodstart":534,"periodend":535,"value":536},{"isodate":510},{"isodate":512},{"valuedate":537,"value":514},"2026-06-01T00:00:00",{"periodstart":539,"periodend":540,"value":541},{"isodate":497},{"isodate":499},{"valuedate":542,"value":501},"2024-10-01T00:00:00",{"periodstart":544,"periodend":545,"value":546},{"isodate":510},{"isodate":512},{"valuedate":547,"value":206},"2026-05-01T00:00:00",{"periodstart":549,"periodend":550,"value":551},{"isodate":517},{"isodate":519},{"valuedate":552,"value":514},"2027-05-01T00:00:00",{"periodstart":554,"periodend":555,"value":556},{"isodate":523},{"isodate":525},{"valuedate":557,"value":514},"2028-05-01T00:00:00",[559,568,578,586,595,604,612,620,628,636,644,652,660,669,677,685],{"transactiontype":560,"transactiondate":561,"value":562,"sector":564,"recipientcountry":567},{"code":224},{"isodate":235},{"valuedate":235,"value":563},2250000,[565,566],{"vocabulary":224,"code":269},{"vocabulary":219,"code":263},{"code":250},{"transactiontype":569,"transactiondate":570,"value":571,"sector":573,"recipientregion":576},{"code":224},{"isodate":235},{"valuedate":235,"value":572},5250000,[574,575],{"vocabulary":224,"code":269},{"vocabulary":219,"code":263},{"code":577},998,{"transactiontype":579,"transactiondate":580,"value":581,"sector":582,"recipientcountry":585},{"code":224},{"isodate":235},{"valuedate":235,"value":572},[583,584],{"vocabulary":224,"code":266},{"vocabulary":219,"code":260},{"code":250},{"transactiontype":587,"transactiondate":588,"value":589,"sector":591,"recipientregion":594},{"code":224},{"isodate":235},{"valuedate":235,"value":590},12250000,[592,593],{"vocabulary":224,"code":266},{"vocabulary":219,"code":260},{"code":577},{"transactiontype":596,"transactiondate":597,"value":599,"sector":600,"recipientcountry":603},{"code":231},{"isodate":598},"2024-11-28T00:00:00",{"valuedate":598,"value":349},[601,602],{"vocabulary":224,"code":266},{"vocabulary":219,"code":260},{"code":250},{"transactiontype":605,"transactiondate":606,"value":607,"sector":608,"recipientcountry":611},{"code":231},{"isodate":598},{"valuedate":598,"value":356},[609,610],{"vocabulary":224,"code":269},{"vocabulary":219,"code":263},{"code":250},{"transactiontype":613,"transactiondate":614,"value":615,"sector":616,"recipientregion":619},{"code":231},{"isodate":598},{"valuedate":598,"value":361},[617,618],{"vocabulary":224,"code":266},{"vocabulary":219,"code":260},{"code":577},{"transactiontype":621,"transactiondate":622,"value":623,"sector":624,"recipientregion":627},{"code":231},{"isodate":598},{"valuedate":598,"value":349},[625,626],{"vocabulary":224,"code":269},{"vocabulary":219,"code":263},{"code":577},{"transactiontype":629,"transactiondate":630,"value":631,"sector":632,"recipientregion":635},{"code":231},{"isodate":499},{"valuedate":499,"value":370},[633,634],{"vocabulary":224,"code":266},{"vocabulary":219,"code":260},{"code":577},{"transactiontype":637,"transactiondate":638,"value":639,"sector":640,"recipientcountry":643},{"code":231},{"isodate":499},{"valuedate":499,"value":375},[641,642],{"vocabulary":224,"code":266},{"vocabulary":219,"code":260},{"code":250},{"transactiontype":645,"transactiondate":646,"value":647,"sector":648,"recipientcountry":651},{"code":231},{"isodate":499},{"valuedate":499,"value":380},[649,650],{"vocabulary":224,"code":269},{"vocabulary":219,"code":263},{"code":250},{"transactiontype":653,"transactiondate":654,"value":655,"sector":656,"recipientregion":659},{"code":231},{"isodate":499},{"valuedate":499,"value":375},[657,658],{"vocabulary":224,"code":269},{"vocabulary":219,"code":263},{"code":577},{"transactiontype":661,"transactiondate":662,"value":664,"sector":665,"recipientcountry":668},{"code":231},{"isodate":663},"2026-06-28T00:00:00",{"valuedate":663,"value":390},[666,667],{"vocabulary":224,"code":269},{"vocabulary":219,"code":263},{"code":250},{"transactiontype":670,"transactiondate":671,"value":672,"sector":673,"recipientregion":676},{"code":231},{"isodate":663},{"valuedate":663,"value":395},[674,675],{"vocabulary":224,"code":266},{"vocabulary":219,"code":260},{"code":577},{"transactiontype":678,"transactiondate":679,"value":680,"sector":681,"recipientregion":684},{"code":231},{"isodate":663},{"valuedate":663,"value":400},[682,683],{"vocabulary":224,"code":269},{"vocabulary":219,"code":263},{"code":577},{"transactiontype":686,"transactiondate":687,"value":688,"sector":689,"recipientcountry":692},{"code":231},{"isodate":663},{"valuedate":663,"value":400},[690,691],{"vocabulary":224,"code":266},{"vocabulary":219,"code":260},{"code":250},[694],{"ref":201,"type":219},{"strategy":696},{"title":697,"strategyObjective":702,"code":350,"strategystartdate":739,"strategyenddate":351,"strategyamount":206,"currency":330},[698,700],{"value":699},"Research cooperation 2022-2028",{"lang":209,"value":701},"Forskningssamarbete 2022-2028",[703,717,728],{"name":704,"thematicArea":709,"code":715,"percentage":716},[705,707],{"value":706},"Enhanced research capacity and sustainable research environments (Sida)",{"lang":209,"value":708},"Stärkt forskningskapacitet och hållbara forskningsmiljöer (Sida)",{"narrative":710},[711,713],{"value":712},"Poverty reduction through job creation, trade and education",{"lang":209,"value":714},"Fattigdomsbekämpning genom jobbskapande, handel och utbildning","FORSK2022a1",20,{"name":718,"thematicArea":723,"code":727,"percentage":429},[719,721],{"value":720},"Enhanced global, regional and national research that is of relevance to the least developed countries and regions (Sida)",{"lang":209,"value":722},"Stärkt global, regional och nationell forskning av relevans för minst utvecklade länder och regioner (Sida)",{"narrative":724},[725,726],{"value":712},{"lang":209,"value":714},"FORSK2022a2",{"name":729,"thematicArea":734,"code":738,"percentage":429},[730,732],{"value":731},"Enhanced impact of research that is of relevance to poverty reduction and sustainable development (Sida)",{"lang":209,"value":733},"Stärkt genomslag för forskning av relevans för fattigdomsbekämpning och hållbar utveckling (Sida)",{"narrative":735},[736,737],{"value":712},{"lang":209,"value":714},"FORSK2022a3","2022-10-01T00:00:00",[741,743,745,747,749,751,753,755,757,759,761,763],{"type":231,"transactionDate":348,"valueDate":742,"value":349,"recipientcountry":603,"recipientregion":140,"sector":600},["Date","2024-11-27T23:00:00.000Z"],{"type":231,"transactionDate":348,"valueDate":744,"value":356,"recipientcountry":611,"recipientregion":140,"sector":608},["Date","2024-11-27T23:00:00.000Z"],{"type":231,"transactionDate":348,"valueDate":746,"value":361,"recipientcountry":140,"recipientregion":619,"sector":616},["Date","2024-11-27T23:00:00.000Z"],{"type":231,"transactionDate":348,"valueDate":748,"value":349,"recipientcountry":140,"recipientregion":627,"sector":624},["Date","2024-11-27T23:00:00.000Z"],{"type":231,"transactionDate":348,"valueDate":750,"value":370,"recipientcountry":140,"recipientregion":635,"sector":632},["Date","2024-12-27T23:00:00.000Z"],{"type":231,"transactionDate":348,"valueDate":752,"value":375,"recipientcountry":643,"recipientregion":140,"sector":640},["Date","2024-12-27T23:00:00.000Z"],{"type":231,"transactionDate":348,"valueDate":754,"value":380,"recipientcountry":651,"recipientregion":140,"sector":648},["Date","2024-12-27T23:00:00.000Z"],{"type":231,"transactionDate":348,"valueDate":756,"value":375,"recipientcountry":140,"recipientregion":659,"sector":656},["Date","2024-12-27T23:00:00.000Z"],{"type":231,"transactionDate":389,"valueDate":758,"value":390,"recipientcountry":668,"recipientregion":140,"sector":665},["Date","2026-06-27T22:00:00.000Z"],{"type":231,"transactionDate":389,"valueDate":760,"value":395,"recipientcountry":140,"recipientregion":676,"sector":673},["Date","2026-06-27T22:00:00.000Z"],{"type":231,"transactionDate":389,"valueDate":762,"value":400,"recipientcountry":140,"recipientregion":684,"sector":681},["Date","2026-06-27T22:00:00.000Z"],{"type":231,"transactionDate":389,"valueDate":764,"value":400,"recipientcountry":692,"recipientregion":140,"sector":689},["Date","2026-06-27T22:00:00.000Z"],[766,768,770,772,741,743,745,747,749,751,753,755,757,759,761,763],{"type":224,"transactionDate":348,"valueDate":767,"value":563,"recipientcountry":567,"recipientregion":140,"sector":564},["Date","2024-07-29T22:00:00.000Z"],{"type":224,"transactionDate":348,"valueDate":769,"value":572,"recipientcountry":140,"recipientregion":576,"sector":573},["Date","2024-07-29T22:00:00.000Z"],{"type":224,"transactionDate":348,"valueDate":771,"value":572,"recipientcountry":585,"recipientregion":140,"sector":582},["Date","2024-07-29T22:00:00.000Z"],{"type":224,"transactionDate":348,"valueDate":773,"value":590,"recipientcountry":140,"recipientregion":594,"sector":591},["Date","2024-07-29T22:00:00.000Z"],[696],{"links":776,"preamble":831,"dateObject":834},[777,786,795,804,813,822],{"id":778,"title":779,"slug":782,"post_id":783,"children":140,"description":140,"description_title":140,"description_swe":140,"description_title_swe":140,"localization":784},216,{"en":780,"sv":781},"About Openaid","Om Openaid","about-openaid",25,{"sv_slug":785},"om-openaid",{"id":787,"title":788,"slug":791,"post_id":792,"children":140,"description":140,"description_title":140,"description_swe":140,"description_title_swe":140,"localization":793},9424,{"en":789,"sv":790},"Contacts","Kontakt","about-openaid\u002Fcontact",49,{"sv_slug":794},"om-openaid\u002Fkontakt",{"id":796,"title":797,"slug":800,"post_id":801,"children":140,"description":140,"description_title":140,"description_swe":140,"description_title_swe":140,"localization":802},221,{"en":798,"sv":799},"Publications","Publikationer","about-openaid\u002Fpublications",158,{"sv_slug":803},"om-openaid\u002Fpublikationer",{"id":805,"title":806,"slug":809,"post_id":810,"children":140,"description":140,"description_title":140,"description_swe":140,"description_title_swe":140,"localization":811},217,{"en":807,"sv":808},"Accessibility of Openaid","Tillgänglighetsredogörelse","about-openaid\u002Faccessibility-of-openaid",156,{"sv_slug":812},"om-openaid\u002Ftillganglighetsredogorelse",{"id":814,"title":815,"slug":818,"post_id":819,"children":140,"description":140,"description_title":140,"description_swe":140,"description_title_swe":140,"localization":820},220,{"en":816,"sv":817},"Privacy notice","Behandling av personuppgifter","about-openaid\u002Fprivacy-notice",42,{"sv_slug":821},"om-openaid\u002Fbehandling-av-personuppgifter",{"id":823,"title":824,"slug":827,"post_id":828,"children":140,"description":140,"description_title":140,"description_swe":140,"description_title_swe":140,"localization":829},222,{"en":825,"sv":826},"Report suspicions of corruption, irregularities, and misconduct","Anmäl misstankar om korruption","about-openaid\u002Freport-suspicions-of-corruption-irregularities-and-misconduct",47,{"sv_slug":830},"om-openaid\u002Fanmal-misstankar-om-korruption-oegentligheter-och-missforhallanden",{"en":832,"sv":833},"Openaid publishes information from agencies and departments in accordance with the transparency guarantee.","På Openaid publiceras information från myndigheter och departement i enlighet med transparensgarantin.",{"lastImport":835,"generatedDate":836},"2026-11-11T07:25:00.211818","2026-11-11T04:29:23+00:00"]